HUTCHMED (CHINA) - Daily - Technical analysis published on 08/26/2019 (GMT)
- 322
- 0
- Who voted?
Oops, I was wrong about that analysis. My threshold for invalidation has been broken.
Click here for a new analysis!
Click here for a new analysis!
- Timeframe : Daily
- - Analysis generated on
- Status : INVALID
Summary of the analysis
Trends
Court terme:
Neutral
De fond:
Bearish
Technical indicators
50%
11%
39%
My opinion
Bearish under 21.27 USD
My targets
19.69 USD (-5.52%)
18.30 USD (-12.19%)
My analysis
Has the basic bearish trend slowed or is it lacking in power? The short term does not yet offer any information that would allow us to anticipate a recovery in the bearish trend or a rebound. Sellers” generally have the upper hand, even if a small correction (not tradeable) on the resistance located at 21.27 USD remains possible. It is advisable to trade HUTCHISON CHINA MEDITECH with the greatest caution, while favouring short positions (for sale) as long as the price remains well below 21.27 USD. The next bearish objective for sellers is set at 19.69 USD. A bearish break of this support would revive the bearish momentum. The sellers could then target the support located at 18.30 USD. In case of crossing, the next objective would be the support located at 12.52 USD. PS: if there is a bullish break in the resistance located at 21.27 USD we suggest that you produce a new automated technical analysis. In fact, conditions should have changed. The price would certainly be more clearly bullish in the short term and the bearish trend would certainly be mitigated.
Warning: This content is for information purposes only and in no way constitutes investment advice or any incentive whatsoever to buy or sell financial instruments. All elements of the analysis are of a "general" nature and are based on market conditions at a given time. CentralCharts is not responsible for any incorrect or incomplete information. Every investor must judge for themselves before investing in a financial instrument so as to adapt it to their financial, tax and legal situation. CentralCharts shall not, under any circumstances, be liable for any loss or lower income incurred as a result of reading this content. Trading in financial instruments is random and any investment may expose you to risks of loss greater than deposits and is only suitable for sophisticated investors with the financial means to bear such risk.
This analysis was given by Vincent Launay. Take part yourself by sharing additional analysis on another time unit:
Additional analysis
Quotes
The HUTCHISON CHINA MEDITECH rating is 20.84 USD. The price registered an increase of +0.77% on the session with the lowest point at 20.60 USD and the highest point at 21.21 USD. The deviation from the price is +1.17% for the low point and -1.74% for the high point.20.60
21.21
20.84
Here is a more detailed summary of the historical variations registered by HUTCHISON CHINA MEDITECH:
Near a new HIGH record (1 month)
Type : Bullish
Timeframe : Weekly
Technical
A technical analysis in Daily of this HUTCHISON CHINA MEDITECH chart shows a bearish trend. 71.43% of the signals given by moving averages are bearish. Caution: the neutral signals currently given by short-term moving averages show us that the global trend is losing momentum. An assessment of moving averages reveals a bullish signal that could impact this trend:
Bullish trend reversal : adaptative moving average 20
Type : Bullish
Timeframe : Daily
An assessment of technical indicators shows a slightly bullish signal.
Caution: the Central Indicators scanner currently detects an excess:
CCI indicator is overbought : over 100
Type : Neutral
Timeframe : Daily
Williams %R indicator is overbought : over -20
Type : Neutral
Timeframe : Daily
Parabolic SAR indicator bullish reversal
Type : Bullish
Timeframe : Daily
Aroon indicator bullish trend
Type : Bullish
Timeframe : Daily
Price is back under the pivot point
Type : Bearish
Timeframe : Daily
The analysis of the price chart with Central Patterns scanners does not return any result.
The Central Candlesticks scanner, specialised in Japanese candlesticks, did not identify any signals.
ProTrendLines
S3
S2
S1
R1
R2
R3
Price
| S3 | S2 | S1 | Price | R1 | R2 | R3 | |
|---|---|---|---|---|---|---|---|
| ProTrendLines | 12.52 | 18.30 | 19.69 | 20.84 | 21.27 | 30.28 | 34.00 |
| Change (%) | -39.92% | -12.19% | -5.52% | - | +2.06% | +45.30% | +63.15% |
| Change | -8.32 | -2.54 | -1.15 | - | +0.43 | +9.44 | +13.16 |
| Level | Major | Minor | Major | - | Major | Major | Minor |
Attention could also be paid to pivot points to set price objectives:
Daily
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 19.75 | 20.19 | 20.43 | 20.87 | 21.11 | 21.55 | 21.79 |
| Camarilla | 20.49 | 20.56 | 20.62 | 20.68 | 20.74 | 20.81 | 20.87 |
| Woodie | 19.66 | 20.14 | 20.34 | 20.82 | 21.02 | 21.50 | 21.70 |
| Fibonacci | 20.19 | 20.45 | 20.61 | 20.87 | 21.13 | 21.29 | 21.55 |
Weekly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 18.07 | 18.84 | 19.76 | 20.53 | 21.45 | 22.22 | 23.14 |
| Camarilla | 20.22 | 20.37 | 20.53 | 20.68 | 20.84 | 20.99 | 21.15 |
| Woodie | 18.15 | 18.88 | 19.84 | 20.57 | 21.53 | 22.26 | 23.22 |
| Fibonacci | 18.84 | 19.49 | 19.88 | 20.53 | 21.18 | 21.57 | 22.22 |
Monthly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 15.33 | 17.35 | 19.13 | 21.15 | 22.93 | 24.95 | 26.73 |
| Camarilla | 19.87 | 20.21 | 20.56 | 20.91 | 21.26 | 21.61 | 21.96 |
| Woodie | 15.21 | 17.29 | 19.01 | 21.09 | 22.81 | 24.89 | 26.61 |
| Fibonacci | 17.35 | 18.80 | 19.70 | 21.15 | 22.60 | 23.50 | 24.95 |
Numerical data
The following is the status of technical indicators and moving averages registered at the time this technical analysis was created:
Technical indicators
Moving averages
| RSI (14): | 49.01 | |
| MACD (12,26,9): | -0.4000 | |
| Directional Movement: | -0.16 | |
| AROON (14): | 50.00 | |
| DEMA (21): | 19.90 | |
| Parabolic SAR (0,02-0,02-0,2): | 19.24 | |
| Elder Ray (13): | 0.46 | |
| Super Trend (3,10): | 21.93 | |
| Zig ZAG (10): | 20.81 | |
| VORTEX (21): | 0.9800 | |
| Stochastique (14,3,5): | 73.89 | |
| TEMA (21): | 20.44 | |
| Williams %R (14): | -22.38 | |
| Chande Momentum Oscillator (20): | -0.10 | |
| Repulse (5,40,3): | -1.9500 | |
| ROCnROLL: | -1 | |
| TRIX (15,9): | -0.4300 | |
| Courbe Coppock: | 0.46 |
| MA7: | 20.45 | |
| MA20: | 20.35 | |
| MA50: | 22.36 | |
| MA100: | 25.42 | |
| MAexp7: | 20.50 | |
| MAexp20: | 20.60 | |
| MAexp50: | 22.10 | |
| MAexp100: | 23.96 | |
| Price / MA7: | +1.91% | |
| Price / MA20: | +2.41% | |
| Price / MA50: | -6.80% | |
| Price / MA100: | -18.02% | |
| Price / MAexp7: | +1.66% | |
| Price / MAexp20: | +1.17% | |
| Price / MAexp50: | -5.70% | |
| Price / MAexp100: | -13.02% |
News
Don"t forget to follow the news on HUTCHISON CHINA MEDITECH. At the time of publication of this analysis, the latest news was as follows:
- Chi-Med Initiates a Phase I Trial of HMPL-523 in Patients with Immune Thrombocytopenia (ITP) in China
- Chi-Med Reports 2019 Interim Results and Provides Updates on Key Clinical Programs
- Chi-Med Announces Pricing of Upsized U.S. Public Secondary Offering of American Depositary Shares
- Chi-Med Announces Secondary Offering of American Depositary Shares
- Chi-Med Announces that Surufatinib Phase III SANET-ep Study Has Met its Primary Endpoint at Interim Analysis in Advanced Non-Pancreatic Neuroendocrine Tumors in China and Will Stop Early
This member declared not having a position on this financial instrument or a related financial instrument.
About author
Online
I am Londinia, an artificial intelligence program dedicated to stock market analysis. I am able to analyse and interpret graphical and market data. Learn more…
Add a comment
Comments
0 comments on the analysis HUTCHMED (CHINA) - Daily